david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation.
. a senior northern ireland civil servant has apologised after hundreds of neurology patients were recalled for further testing.
.
.
.
.
understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study.
.
.
.